Evidence map›Paper›PMID 29497973›Full record

ArticleEndocrine2018

Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.

Francesca Marini, Francesca Giusti, Caterina Fossi, Federica Cioppi, Luisella Cianferotti, Laura Masi, Francesca Boaretto, Stefania Zovato, Filomena Cetani, Annamaria Colao and 17 more

Erratum issued Registry-linked trialOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06790251 (Creation, Management and Analysis of a National Database of Patients With Multiple Endocrine Neoplasia Type 1), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06790251 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Creation, Management and Analysis of a National Database of Patients With Multiple Endocrine Neoplasia Type 1 (MENNET1 Database)

Typeobservational_patient_registrySponsorF.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo SettoreRan2025 to 2035Enrolled600ConditionsMultiple Endocrine Neoplasia Type 1
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Phenotypic presentation ofOxford medical case reports · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Inherited syndromes involving pancreatic neuroendocrine tumors.Journal of gastrointestinal oncology · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 14 institutions in 2 countries.

Francesca MariniDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Francesca GiustiDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Caterina FossiDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Federica CioppiDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Luisella CianferottiDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Laura MasiDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Francesca BoarettoFamilial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padua, Italy.
Stefania ZovatoFamilial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padua, Italy.
Filomena CetaniDepartment of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, Pisa, Italy.
Annamaria ColaoEndocrinology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Maria Vittoria DavìInternal Medicine, Section of Endocrinology, Department of Medicine, University of Verona, Verona, Italy.
Antongiulio FaggianoEndocrinology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Giuseppe FanciulliNET Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy.
Piero FerollaMultidisciplinar NET Center, Umbria Regional Cancer Network, Azienda Ospedaliera di Perugia and University of Perugia, Perugia, Italy.
Diego FeroneEndocrinology Unit, Department of Internal Medicine and Medical Specialties (DiMI), Policlinico San Martino, University of Genoa, Genoa, Italy.
Paola LoliDepartment of Endocrinology, Hospital Niguarda Ca' Granda, Milan, Italy.
Franco ManteroDivision of Endocrinology, Department of Medicine (DIMED), University of Padua, Padua, Italy.
Claudio MarcocciDepartment of Clinical and Experimental Medicine, Section of Endocrinology, University of Pisa, Pisa, Italy.
Giuseppe OpocherFamilial Cancer Clinic, Veneto Institute of Oncology IRCCS, Padua, Italy.
Paolo Beck-PeccozUniversity of Milan, Milan, Italy.
Luca PersaniDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Alfredo ScillitaniUnit of Endocrinology 'Casa Sollievo della Sofferenza' Hospital, IRCCS, San Giovanni Rotondo, Foggia, Italy.
Fabiana GuizzardiDivision of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Anna SpadaDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Paola TomassettiDepartment of Medical and Surgical Sciences, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Francesco TonelliDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy.
Maria Luisa BrandiDepartment of Surgery and Translational Medicine, University of Florence, Florence, Italy. marialuisa.brandi@unifi.it.ORCID http://orcid.org/0000-0002-8741-0592
University of Florence · ITIstituto Oncologico Veneto · ITUniversity of Milan · ITUniversity of Naples Federico II · ITUniversity of Pisa · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCasa Sollievo della Sofferenza · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITIRCCS Istituto Auxologico Italiano · ITOspedale Policlinico San Martino · ITUniversity of Padua · ITUniversity of Perugia · ITUniversity of Sassari · ITUniversity of Verona · IT

Funding

Ente Cassa di Risparmio di Firenze 2014/0431
6 · The paper itself

Abstract

purposeMultiple endocrine neoplasia type 1 (MEN1) is caused by germline inactivating mutations of the MEN1 gene. Currently, no direct genotype-phenotype correlation is identified. We aim to analyze MEN1 mutation site and features, and possible correlations between the mutation type and/or the affected menin functional domain and clinical presentation in patients from the Italian multicenter MEN1 database, one of the largest worldwide MEN1 mutation series published to date.

methodsThe study included the analysis of MEN1 mutation profile in 410 MEN1 patients [370 familial cases from 123 different pedigrees (48 still asymptomatic at the time of this study) and 40 single cases].

resultsWe identified 99 different mutations: 41 frameshift [small intra-exon deletions (28) or insertions (13)], 13 nonsense, 26 missense and 11 splicing site mutations, 4 in-frame small deletions, and 4 intragenic large deletions spanning more than one exon. One family had two different inactivating MEN1 mutations on the same allele. Gastro-entero-pancreatic tumors resulted more frequent in patients with a nonsense mutation, and thoracic neuroendocrine tumors in individuals bearing a splicing-site mutation.

conclusionsOur data regarding mutation type frequency and distribution are in accordance with previously published data: MEN1 mutations are scattered through the entire coding region, and truncating mutations are the most common in MEN1 syndrome. A specific direct correlation between MEN1 genotype and clinical phenotype was not found in all our families, and wide intra-familial clinical variability and variable disease penetrance were both confirmed, suggesting a role for modifying, still undetermined, factors, explaining the variable MEN1 tumorigenesis.

Indexed as

Germ-Line MutationAdolescentAdultAgedChildChild, PreschoolDatabases, FactualFemaleGenotypeHumansItalyMaleMiddle AgedMultiple Endocrine Neoplasia Type 1PhenotypeProto-Oncogene ProteinsMEN1 protein, humanProto-Oncogene ProteinsGenetic testGenotype–phenotype correlationMEN1 inactivating mutationsMultiple endocrine neoplasia type 1

Identifiers

PMID29497973
OpenAlexW2790380013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.